Biotech Analysts Split on OvaScience Inc (NASDAQ:OVAS)



OvaScience Inc. (NASDAQ:OVAS) last traded at $6.26 after moving down -13.66% for the trading day. The company last released their quarterly earnings results on 11-05-15 for the period ended Sep-15. The company reported earnings of -$0.66 against a Zack’s research estimate of -$0.66. This represents a 0.00% surprise on the expected result. [Trend Analysis]

The current average broker recommendation for OvaScience Inc., according to Zack’s research, is 1.86, based on 7 broker ratings. With 1 being a strong buy and 5 being a strong sell, this means that on a consensus basis, analysts currently see OvaScience Inc. as a buy. The 12 month target consensus price estimate among these analysts for OvaScience Inc. is currently at $31.60.

Out of the 7 broker recommendations for OVAS, 4 recommend it as a strong buy, 0 as a buy, 3 as a hold 0 as a sell and 0 as a strong sell.

For the current quarter, the consensus analyst estimate for OvaScience Inc. (NASDAQ:OVAS) is $0.69, with analysts expecting year on year growth for the company of 12.15%

About OvaScience Inc. (NASDAQ:OVAS)

OvaScience, Inc. is a life science company focused on the discovery, development and commercialization of new treatments for infertility. Its product includes Augment for the treatment of infertility and Ova Ture used in the creation of mature fertilizable eggs

Leave A Reply